Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-08-03Interactions of Fronto-Parietal High Frequency Repetitive Transcranial Magnetic Stimulation on Anterior Cingulate Cortex Activation in Schizophrenia
-
CLINICAL_TRIALS study record update · 2023-08-03Adapting the Tumor Board Model for Mental Illness and Cancer: A Single Arm Pilot Trial
-
CLINICAL_TRIALS study record update · 2023-07-28Repetitive Transcranial Magnetic Stimulation (rTMS) as a Probe of Episodic Memory (EM) Neurocircuitry in Schizophrenia
-
CLINICAL_TRIALS study record update · 2023-07-28Bizarreness and Anomalous Self Experiences in Schizophrenia: Pilot Study on Diagnostic Decision-Making
-
CLINICAL_TRIALS study record update · 2023-07-28A Phase Ⅰb/Ⅱ, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Investigate the Safety, Tolerability, Pharmacokinetics and Efficacy of HS-10380 in Chinese Adults With Schizophrenia.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-07-27A Phase 1, Open-label Trial to Evaluate Target Occupancy of CVL-231 at Muscarinic Receptors Type 4 in Brain Following Single Oral Doses Using Positron Emission Tomography in Healthy Adult Subjects
-
CLINICAL_TRIALS study record update · 2023-07-25Berberine Effects on Clinical Symptoms and Metabolic Disturbance as an Adjunctive Therapy in Patients With Schizophrenia: a Randomized Double-blind Placebo-controlled Study
-
CLINICAL_TRIALS study record update · 2023-07-21A Randomized Controlled Trial of Adjunctive Siltuximab in Schizophrenia
-
CLINICAL_TRIALS study record update · 2023-07-21A Randomized Controlled Trial of Adjunctive Tocilizumab in Schizophrenia
-
CLINICAL_TRIALS study record update · 2023-07-20The Effect Of Visual Arts Group Therapy Based On Watson's Human Care Model On Perceived Social Support And Functional Recovery In Individuals With Schizophrenia
-
CLINICAL_TRIALS study record update · 2023-07-17A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate Prevention of Relapse in Patients With Schizophrenia Receiving Either Flexible Dose Iloperidone or Placebo in Long-term Use (up to 26 Weeks) Followed by up to 52 Weeks of Open-label Extension
-
CLINICAL_TRIALS study record update · 2023-07-17Insights From Participants: Candid Accounts of Schizophrenia Clinical Trials Patients
-
CLINICAL_TRIALS study record update · 2023-07-11Post-Hospital Suicide Prevention Intervention for Patients With Schizophrenia-Spectrum Disorders
-
CLINICAL_TRIALS study record update · 2023-07-10Comparison of Physical Fitness, Physical Activity Level, Depression and Quality of Life in Patients With Bipolar Disorder and Schizophrenia With Healthy Controls
-
CLINICAL_TRIALS study record update · 2023-07-03Evaluation of Physical Activity, Physical Fitness, and Quality of Life in Patients With Schizophrenia Utilized From Community Mental Health Center Services
-
CLINICAL_TRIALS study record update · 2023-06-29An Open-label, Adaptive, Repeat-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Iloperidone Long-acting Injection (LAI) in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2023-06-23Cognitive Effects of Nimodipine in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2023-06-22Optimizing Treatment Protocol of High Frequency Repetitive Transcranial Magnetic Stimulation for Cognitive Deficits and Negative Symptoms in Schizophrenia: an Exploratory Study
-
CLINICAL_TRIALS study record update · 2023-06-22Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness
-
CLINICAL_TRIALS study record update · 2023-06-18A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Study To Determine Efficacy and Safety of BXCL501 In Agitation Associated With Schizophrenia
-
CLINICAL_TRIALS study record update · 2023-06-18A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Study To Determine Efficacy and Safety of BXCL501 In Agitation Associated With Schizophrenia
-
CLINICAL_TRIALS study record update · 2023-06-15A Randomized, Double-blind, Parallel-group Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment
-
CLINICAL_TRIALS study record update · 2023-06-15Prebiotic Treatment in People With Schizophrenia
-
CLINICAL_TRIALS study record update · 2023-06-08Brain Health: Effects of Exercise on Hippocampal Volume and Memory Deficits in Persons With Schizophrenia
-
CLINICAL_TRIALS study record update · 2023-06-02The Motor Neurological Soft Signs (MNSS) in Persons With Schizophrenia